Previous 10 | Next 10 |
Since eye care provider Alcon ( ALC ) was spun off from Novartis ( NVS ) in April, the case for ALC stock has centered on the company's multi-year transformation effort. Alcon struggled as part of Novartis, who bought the company at a $52 billion valuation back in 2011. Revenue, per Novartis...
For a couple of years, AeroAnalysis has been tracking the monthly order inflow for Boeing ( BA ) and Airbus ( OTCPK:EADSF ) ( OTCPK:EADSY ) aircraft. The monthly coverage is not so much there to invoke any Boeing vs. Airbus rhetoric, but it gives us some valuable insights. A single month...
Image source: The Motley Fool. Alcon Inc (NYSE: ALC) Q3 2019 Earnings Call Nov 20, 2019 , 7:00 a.m. ET Operator Continue reading
Alcon, Inc. (ALC) Q3 2019 Earnings Conference Call November 20, 2019, 08:00 AM ET Company Participants Karen King - SVP of IR and Communications David Endicott - CEO Tim Stonesifer - CFO Conference Call Participants James Gordon - JP Morgan Sebastian Walker - UBS Larry ...
The following slide deck was published by Alcon, Inc. in conjunction with their 2019 Q3 earnings Read more ...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). Emirates and Boeing are reportedly on the verge of striking a compromise deal for the Middle East's ...
Alcon (NYSE: ALC ): Q3 Non-GAAP EPS of $0.46 in-line; GAAP EPS of -$0.14 misses by $0.06 . Revenue of $1.84B (+4.5% Y/Y) beats by $10M . Press Release More news on: Alcon, Inc., Earnings news and commentary, Healthcare stocks news,
Third quarter sales of $1.8 billion, an increase of 4%, or 6% constant currency (cc) Expands new product pipeline with the successful launch of PanOptix and PRECISION1 in the US Announces a transformation program that reinvests savings into strategic growth initiatives su...
This article is part of a series that provides an ongoing analysis of the changes made to George Soros’s 13F stock portfolio on a quarterly basis. It is based on George Soros’s regulatory 13F Form filed on 11/14/2019. Please visit our Tracking Soros Fund Management Holdings ar...
This article is part of a series that provides an ongoing analysis of the changes made to Kahn Brothers' 13F stock portfolio on a quarterly basis. It is based on Kahn Brothers' regulatory 13F Form filed on 11/05/2019. Please visit our Tracking Kahn Brothers Portfolio series to get an idea ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 17:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Combined vitreoretinal-cataract system (VCS) and standalone cataract system (CS) are cleared for use in the U.S. New, proprietary technologies designed to deliver transformative surgical innovation Alcon to immediately begin collecting real-world user experience in the U.S. prior ...
2024-06-09 17:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...